Long-Acting Lipoglycopeptides: "Lineless Antibiotics" for Serious Infections in Persons Who Use Drugs.

Michael J RybakMatthew A MillerBrian T MontagueGerard R BarberR Brett McQueenMartin Kršák

Published in: Open forum infectious diseases (2019)

Long-acting lipoglycopeptides may be equally effective as standard-of-care, present a safety advantage, and secure earlier discharge and significant cost-savings.

Keyphrases

healthcare
palliative care
quality improvement
pain management
affordable care act